Based on Codiak see should be in the 60s on Monday. This is without all the good news in the update and that could come into fruition in 2021 and anything else left of field. This is reminding me of when NOX ran to $1.32 in the early days. I think this company is much better.
- Forums
- ASX - By Stock
- TYP
- Codiak Biosciences ($200m market cap)
Codiak Biosciences ($200m market cap), page-64
Featured News
Add TYP (ASX) to my watchlist
(20min delay)
|
|||||
Last
4.9¢ |
Change
0.000(0.00%) |
Mkt cap ! $60.10M |
Open | High | Low | Value | Volume |
5.0¢ | 5.1¢ | 4.6¢ | $297.0K | 6.063M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 12000 | 4.8¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
4.9¢ | 249224 | 2 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 12000 | 0.048 |
1 | 260000 | 0.047 |
1 | 54347 | 0.046 |
5 | 1069599 | 0.045 |
2 | 300000 | 0.044 |
Price($) | Vol. | No. |
---|---|---|
0.049 | 249224 | 2 |
0.050 | 158497 | 2 |
0.053 | 200759 | 2 |
0.054 | 285561 | 4 |
0.055 | 192266 | 1 |
Last trade - 16.10pm 15/11/2024 (20 minute delay) ? |
Featured News
TYP (ASX) Chart |
The Watchlist
ACW
ACTINOGEN MEDICAL LIMITED
Will Souter, CFO
Will Souter
CFO
Previous Video
Next Video
SPONSORED BY The Market Online